Neoadjuvant therapy offers longer survival than upfront surgery for poorly differentiated and higher stage pancreatic cancer.

Nurmi, Anna; Mustonen, Harri; Parviainen, Helka; Peltola, Katriina; Haglund, Caj; Seppänen, Hanna

Nurmi, Anna; Mustonen, Harri; Parviainen, Helka; Peltola, Katriina; Haglund, Caj; Seppänen, Hanna.

Afiliação

Nurmi A; a Department of Surgery , Helsinki University Hospital, University of Helsinki , Helsinki , Finland.
Mustonen H; a Department of Surgery , Helsinki University Hospital, University of Helsinki , Helsinki , Finland.
Parviainen H; b HUS Medical Imaging Centre, Radiology, Helsinki University Hospital, University of Helsinki , Helsinki , Finland.
Peltola K; c Comprehensive Cancer Centre, Helsinki University Hospital, University of Helsinki , Helsinki , Finland.
Haglund C; a Department of Surgery , Helsinki University Hospital, University of Helsinki , Helsinki , Finland.
Seppänen H; d Research Programs Unit , Translational Cancer Biology, University of Helsinki , Helsinki , Finland.

Acta Oncol ; 57(6): 799-806, 2018 Jun.

Article em En | MEDLINE | ID: mdl-29241394

Assuntos

Carcinoma Ductal Pancreático/terapia; Terapia Neoadjuvante/métodos; Neoplasias Pancreáticas/terapia; Adulto; Idoso; Idoso de 80 Anos ou mais; Carcinoma Ductal Pancreático/mortalidade; Carcinoma Ductal Pancreático/patologia; Quimioterapia Adjuvante/métodos; Intervalo Livre de Doença; Feminino; Humanos; Masculino; Pessoa de Meia-Idade; Pancreatectomia; Neoplasias Pancreáticas/mortalidade; Neoplasias Pancreáticas/patologia; Radioterapia Adjuvante/métodos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Terapia Neoadjuvante / Carcinoma Ductal Pancreático Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google